Overview
Lauren Ferrante is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in New Haven, Connecticut. Dr. Ferrante is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), Pneumonia, and Acute Respiratory Distress Syndrome (ARDS).
Her clinical research consists of co-authoring 72 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 13 articles in the study of COVID-19.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
789 Howard Ave, New Haven, CT 06519
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Montefiore Medical Center
Michelle N. Gong, MD, MS, is a Professor of Medicine and Epidemiology and Population Health at Albert Einstein College of Medicine. She is also the Chief of Critical Care Medicine, Associate Chief of Academic Affairs, and Director of Critical Care Research at Montefiore. Dr. Gong’s clinical focus is on critical care delivery, predictive analytics, and process improvements, such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit, which has reduced the duration of mechanical ventilation, length of stay, hospital costs, and ICU complications. She joined the Einstein/Montefiore faculty in July 2009. Dr. Gong received an Engineering degree at the University of Pennsylvania. She then went on to earn her Doctor of Medicine at the Yale University School of Medicine. She completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women’s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. Dr. Gong studied at the Harvard School of Public Health, receiving her Master’s Degree in Clinical Epidemiology. Dr. Gong has spent her career improving outcomes in patients along the entire continuum of critical illness, from its development to progression and recovery, with an overall focus on the prediction and prevention of acute organ failure and its complications. Her current research ranges from acute respiratory distress syndrome to prevention of delirium, treatment of severe influenza, big data and predictive analysis in risk prediction, and effective clinical decision support systems. Under her leadership, Montefiore/Einstein was selected as a clinical center for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network which represents the first representation of a medical center from the New York and the tri-state area. Collaborating with the research informatics and healthcare industries, Dr. Gong has fostered the application of informatic approaches to drive improvement in healthcare delivery and research. Dr. Gong is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Severe Acute Respiratory Syndrome (SARS), and Cerebral Hypoxia.
Ny Metro Sleep Medical, P.C.
Rajendra Rampersaud is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Bronx, New York. Dr. Rampersaud is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, COVID-19, and Gastrostomy.
Charles Dela-Cruz is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in New Haven, Connecticut. Dr. Dela-Cruz is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Pneumonia, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Acute Respiratory Distress Syndrome (ARDS).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- COVID-19Dr. Ferrante isDistinguished. Learn about COVID-19.
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)Dr. Ferrante isExperienced. Learn about Acute Respiratory Distress Syndrome (ARDS).
- PneumoniaDr. Ferrante isExperienced. Learn about Pneumonia.
- Severe Acute Respiratory Syndrome (SARS)Dr. Ferrante isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).

